WN
MYGN icon

Williams & Novak’s Myriad Genetics MYGN Stock Holding History

Williams & Novak’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.8K Buy
+15,500
New +$65.4K 0.04% 138

Other funds holding MYGN

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Williams & Novak's MYGN Position: Q3 2026 in Review

Williams & Novak opened a new position in Myriad Genetics (MYGN) in Q3 2026: 15,500 shares worth $66.8K. The stake represents 0.04% of the portfolio and ranks #138 among its holdings.

3 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Williams & Novak held 15,500 shares of Myriad Genetics worth $66.8K as of Q3 2026.
  • Myriad Genetics was a new Williams & Novak position in Q3 2026.
  • Myriad Genetics made up 0.04% of Williams & Novak's portfolio in Q3 2026, its #138 holding.
  • 3 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.